# Resorba Medical GmbH

- Location (FDA's records): Nuremberg, DE
- FDA decisions: 4 (2014–2018): 4 510(k) clearances
- Product codes: GAM (2), GAT (1), GAW (1)
- Predicates its devices cite: 17 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Aesculap, Inc.: 3 (https://510kreport.com/company/aesculap)
- ETHICON, Inc.: 2 (https://510kreport.com/company/ethicon)
- Davis & Geck, Inc.: 2 (https://510kreport.com/company/davis-geck)
- Samyang Corp.: 1 (https://510kreport.com/company/samyang)
- Peters Surgical: 1 (https://510kreport.com/company/peters-surgical)
- Riverpoint Medical: 1 (https://510kreport.com/company/riverpoint-medical)
- Foosin Medical Supplies Inc., Ltd.: 1 (https://510kreport.com/company/foosin-medical-supplies)
- Genzyme Corp.: 1 (https://510kreport.com/company/genzyme)

## Recent decisions
- K181320: Caprolon (Sep 18, 2018)
- K143584: Pga Resorba, Pga Resoquick, Glycolon (Nov 2, 2015)
- K143582: Mopylen, Resopren, Silk, Polyester, Nylon, Resolon, Polyamide Pseudo, Steel (Oct 29, 2015)
- K141072: Supolene (Jun 23, 2014)

Source page: https://510kreport.com/company/resorba-medical